Medical Terminology

reboxetine

Reboxetine (Davedex, Edronax, Irenor, Norebox, Prolift, Solvex, Yeluoshu, Zuolexin) belongs to a group of medicines called norepinephrine reuptake inhibitors (NRIs), and is marketed as an antidepressant for the use in the treatment of major depression. Reboxetine is very similar to atomoxetine. Although reboxetine is approved for use in Europe and elsewhere, it is not currently approved in the U.S. However, in October 2018, the U.S. FDA granted Orphan Drug Designation (ODD) status to Axsome Therapeutics’ AXS-12 (reboxetine) for the treatment of narcolepsy symptoms. Read more about reboxetine on HF’s Treatment web page HERE.